568.53
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché META Giù?
Forum
Previsione
Precedente Chiudi:
$589.85
Aprire:
$589.75
Volume 24 ore:
14.20M
Relative Volume:
0.81
Capitalizzazione di mercato:
$1.45T
Reddito:
$214.96B
Utile/perdita netta:
$70.59B
Rapporto P/E:
20.67
EPS:
27.5066
Flusso di cassa netto:
$48.25B
1 W Prestazione:
-4.44%
1M Prestazione:
-11.99%
6M Prestazione:
-11.07%
1 anno Prestazione:
-27.60%
Meta Platforms Inc Stock (META) Company Profile
Nome
Meta Platforms Inc
Settore
Industria
Telefono
650-543-4800
Indirizzo
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, DASH
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
META
Meta Platforms Inc
|
568.38 | 1.50T | 214.96B | 70.59B | 48.25B | 27.51 |
|
GOOGL
Alphabet Inc
|
343.82 | 4.23T | 446.32B | 244.21B | 53.27B | 19.91 |
|
GOOG
Alphabet Inc
|
341.33 | 4.20T | 446.32B | 244.21B | 53.27B | 19.91 |
|
SPOT
Spotify Technology Sa
|
491.51 | 105.43B | 20.32B | 3.16B | 3.82B | 12.55 |
|
DASH
Doordash Inc
|
212.87 | 94.03B | 14.72B | 923.00M | 1.75B | 2.0994 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-07-30 | Reiterato | Monness Crespi & Hardt | Buy |
| 2026-07-16 | Ripresa | Wedbush | Neutral |
| 2026-07-10 | Reiterato | Citizens | Mkt Outperform |
| 2026-07-07 | Aggiornamento | Erste Group | Hold → Buy |
| 2026-06-02 | Aggiornamento | Arete | Neutral → Buy |
| 2026-05-20 | Reiterato | Wells Fargo | Overweight |
| 2026-05-05 | Reiterato | Mizuho | Outperform |
| 2026-04-30 | Downgrade | JP Morgan | Overweight → Neutral |
| 2026-04-10 | Reiterato | Wolfe Research | Outperform |
| 2026-04-09 | Reiterato | Rosenblatt | Buy |
| 2026-04-02 | Downgrade | Erste Group | Buy → Hold |
| 2026-03-30 | Reiterato | Morgan Stanley | Overweight |
| 2026-03-05 | Downgrade | Arete | Buy → Neutral |
| 2026-03-05 | Aggiornamento | Erste Group | Hold → Buy |
| 2026-02-23 | Reiterato | Wells Fargo | Overweight |
| 2026-01-29 | Reiterato | Canaccord Genuity | Buy |
| 2026-01-29 | Reiterato | Cantor Fitzgerald | Overweight |
| 2026-01-29 | Reiterato | Deutsche Bank | Buy |
| 2026-01-29 | Reiterato | Evercore ISI | Outperform |
| 2026-01-29 | Reiterato | Guggenheim | Buy |
| 2026-01-29 | Reiterato | JP Morgan | Overweight |
| 2026-01-29 | Reiterato | Jefferies | Buy |
| 2026-01-29 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Reiterato | Mizuho | Outperform |
| 2026-01-29 | Reiterato | Monness Crespi & Hardt | Buy |
| 2026-01-29 | Reiterato | Morgan Stanley | Overweight |
| 2026-01-29 | Reiterato | Piper Sandler | Overweight |
| 2026-01-29 | Reiterato | Pivotal Research Group | Buy |
| 2026-01-29 | Reiterato | Robert W. Baird | Outperform |
| 2026-01-29 | Reiterato | Roth Capital | Buy |
| 2026-01-29 | Reiterato | Stifel | Buy |
| 2026-01-29 | Reiterato | UBS | Buy |
| 2026-01-29 | Reiterato | Wedbush | Outperform |
| 2026-01-29 | Reiterato | Wells Fargo | Overweight |
| 2026-01-29 | Reiterato | Wolfe Research | Outperform |
| 2026-01-26 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | Reiterato | Raymond James | Strong Buy |
| 2026-01-26 | Aggiornamento | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | Reiterato | Stifel | Buy |
| 2026-01-13 | Reiterato | TD Cowen | Buy |
| 2026-01-12 | Reiterato | Wells Fargo | Overweight |
| 2026-01-08 | Reiterato | Cantor Fitzgerald | Overweight |
| 2026-01-08 | Reiterato | Guggenheim | Buy |
| 2025-12-04 | Aggiornamento | Arete | Neutral → Buy |
| 2025-11-24 | Iniziato | BNP Paribas Exane | Outperform |
| 2025-11-10 | Downgrade | Erste Group | Buy → Hold |
| 2025-10-30 | Reiterato | Barclays | Overweight |
| 2025-10-30 | Reiterato | Bernstein | Outperform |
| 2025-10-30 | Reiterato | BofA Securities | Buy |
| 2025-10-30 | Reiterato | Citigroup | Buy |
| 2025-10-30 | Reiterato | JP Morgan | Overweight |
| 2025-10-30 | Reiterato | Jefferies | Buy |
| 2025-10-30 | Reiterato | Mizuho | Outperform |
| 2025-10-30 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-10-30 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-10-30 | Reiterato | Piper Sandler | Overweight |
| 2025-10-30 | Reiterato | Stifel | Buy |
| 2025-10-30 | Downgrade | The Benchmark Company | Buy → Hold |
| 2025-10-20 | Reiterato | Oppenheimer | Outperform |
| 2025-10-07 | Reiterato | Wells Fargo | Overweight |
| 2025-09-30 | Iniziato | Mizuho | Outperform |
| 2025-07-31 | Reiterato | BMO Capital Markets | Market Perform |
| 2025-07-31 | Reiterato | Bernstein | Outperform |
| 2025-07-31 | Reiterato | BofA Securities | Buy |
| 2025-07-31 | Reiterato | Citigroup | Buy |
| 2025-07-31 | Reiterato | Citizens JMP | Mkt Outperform |
| 2025-07-31 | Reiterato | JP Morgan | Overweight |
| 2025-07-31 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-07-31 | Reiterato | Morgan Stanley | Overweight |
| 2025-07-31 | Reiterato | Oppenheimer | Outperform |
| 2025-07-31 | Reiterato | Pivotal Research Group | Buy |
| 2025-07-31 | Reiterato | TD Cowen | Buy |
| 2025-07-31 | Reiterato | UBS | Buy |
| 2025-07-31 | Reiterato | Wedbush | Outperform |
| 2025-07-31 | Reiterato | Wells Fargo | Overweight |
| 2025-07-28 | Reiterato | Guggenheim | Buy |
| 2025-07-16 | Reiterato | Canaccord Genuity | Buy |
| 2025-07-03 | Aggiornamento | Needham | Underperform → Hold |
| 2025-06-26 | Reiterato | UBS | Buy |
| 2025-06-24 | Reiterato | Citigroup | Buy |
| 2025-05-01 | Reiterato | BofA Securities | Buy |
| 2025-05-01 | Reiterato | Citigroup | Buy |
| 2025-05-01 | Reiterato | Evercore ISI | Outperform |
| 2025-05-01 | Reiterato | Goldman | Buy |
| 2025-05-01 | Reiterato | Guggenheim | Buy |
| 2025-05-01 | Reiterato | JP Morgan | Overweight |
| 2025-05-01 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | Reiterato | MoffettNathanson | Buy |
| 2025-05-01 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-05-01 | Reiterato | Morgan Stanley | Overweight |
| 2025-05-01 | Reiterato | Oppenheimer | Outperform |
| 2025-05-01 | Reiterato | Piper Sandler | Overweight |
| 2025-05-01 | Reiterato | Pivotal Research Group | Buy |
| 2025-05-01 | Reiterato | Raymond James | Strong Buy |
| 2025-05-01 | Reiterato | Rosenblatt | Buy |
| 2025-05-01 | Reiterato | Roth Capital | Buy |
| 2025-05-01 | Reiterato | Stifel | Buy |
| 2025-05-01 | Reiterato | Truist | Buy |
| 2025-05-01 | Reiterato | UBS | Buy |
| 2025-05-01 | Reiterato | Wedbush | Outperform |
| 2025-04-14 | Reiterato | Citigroup | Buy |
| 2025-04-10 | Reiterato | Piper Sandler | Overweight |
| 2025-01-30 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2025-01-23 | Reiterato | BofA Securities | Buy |
| 2025-01-22 | Reiterato | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Reiterato | Jefferies | Buy |
| 2025-01-03 | Reiterato | Wolfe Research | Outperform |
| 2024-10-31 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-10-31 | Reiterato | Pivotal Research Group | Buy |
| 2024-10-11 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-09 | Reiterato | Cantor Fitzgerald | Overweight |
| 2024-10-01 | Iniziato | Pivotal Research Group | Buy |
| 2024-09-30 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-09-10 | Iniziato | DA Davidson | Buy |
| 2024-09-05 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-01 | Reiterato | BofA Securities | Buy |
| 2024-07-19 | Reiterato | Oppenheimer | Outperform |
| 2024-07-16 | Iniziato | Wolfe Research | Outperform |
| 2024-07-10 | Reiterato | TD Cowen | Buy |
| 2024-07-08 | Reiterato | Wells Fargo | Overweight |
| 2024-07-01 | Reiterato | Raymond James | Strong Buy |
| 2024-06-12 | Reiterato | BMO Capital Markets | Market Perform |
| 2024-05-02 | Iniziato | Exane BNP Paribas | Underperform |
| 2024-04-25 | Reiterato | Oppenheimer | Outperform |
| 2024-04-15 | Reiterato | Citigroup | Buy |
| 2024-04-11 | Reiterato | Piper Sandler | Overweight |
| 2024-04-08 | Reiterato | Oppenheimer | Outperform |
| 2024-04-04 | Reiterato | Jefferies | Buy |
| 2024-02-02 | Reiterato | Guggenheim | Buy |
| 2024-02-02 | Reiterato | JMP Securities | Mkt Outperform |
| 2024-02-02 | Reiterato | JP Morgan | Overweight |
| 2024-02-02 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | Reiterato | Mizuho | Buy |
| 2024-02-02 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Reiterato | Morgan Stanley | Overweight |
| 2024-02-02 | Reiterato | Oppenheimer | Outperform |
| 2024-02-02 | Reiterato | Piper Sandler | Overweight |
| 2024-02-02 | Reiterato | ROTH MKM | Buy |
| 2024-02-02 | Reiterato | Raymond James | Strong Buy |
| 2024-02-02 | Reiterato | Robert W. Baird | Outperform |
| 2024-02-02 | Reiterato | Seaport Research Partners | Buy |
| 2024-02-02 | Reiterato | Stifel | Buy |
| 2024-02-02 | Reiterato | Susquehanna | Positive |
| 2024-02-02 | Reiterato | TD Cowen | Outperform |
| 2024-02-02 | Reiterato | UBS | Buy |
| 2024-02-02 | Reiterato | Wedbush | Outperform |
| 2024-02-02 | Reiterato | Wells Fargo | Overweight |
| 2024-02-02 | Reiterato | Wolfe Research | Outperform |
| 2024-01-23 | Reiterato | Citigroup | Buy |
| 2024-01-17 | Reiterato | Piper Sandler | Overweight |
| 2024-01-17 | Reiterato | Wells Fargo | Overweight |
| 2024-01-09 | Iniziato | BMO Capital Markets | Market Perform |
| 2023-12-20 | Ripresa | Raymond James | Strong Buy |
| 2023-10-24 | Iniziato | Seaport Research Partners | Buy |
| 2023-08-22 | Iniziato | Wedbush | Outperform |
| 2023-08-01 | Reiterato | Argus | Buy |
| 2023-07-28 | Aggiornamento | China Renaissance | Hold → Buy |
| 2023-07-27 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2023-07-27 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | Reiterato | Mizuho | Buy |
| 2023-07-25 | Aggiornamento | New Street | Neutral → Buy |
| 2023-07-19 | Reiterato | Jefferies | Buy |
| 2023-07-19 | Reiterato | Truist | Buy |
| 2023-07-17 | Reiterato | Credit Suisse | Outperform |
| 2023-07-17 | Reiterato | Goldman | Buy |
| 2023-07-17 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-07-13 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | Reiterato | Deutsche Bank | Buy |
| 2023-06-08 | Iniziato | Wells Fargo | Equal Weight |
| 2023-05-15 | Aggiornamento | Loop Capital | Hold → Buy |
| 2023-04-27 | Reiterato | Credit Suisse | Outperform |
| 2023-04-27 | Reiterato | Deutsche Bank | Buy |
| 2023-04-27 | Reiterato | Evercore ISI | Outperform |
| 2023-04-27 | Reiterato | Goldman | Buy |
| 2023-04-27 | Reiterato | Guggenheim | Buy |
| 2023-04-27 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-04-27 | Reiterato | JP Morgan | Overweight |
| 2023-04-27 | Reiterato | Mizuho | Buy |
| 2023-04-27 | Reiterato | Monness Crespi & Hardt | Buy |
| 2023-04-27 | Reiterato | Morgan Stanley | Overweight |
| 2023-04-27 | Reiterato | Oppenheimer | Outperform |
| 2023-04-27 | Reiterato | Piper Sandler | Overweight |
| 2023-04-27 | Reiterato | RBC Capital Mkts | Outperform |
| 2023-04-27 | Reiterato | Raymond James | Outperform |
| 2023-04-27 | Reiterato | Robert W. Baird | Outperform |
| 2023-04-27 | Reiterato | Rosenblatt | Buy |
| 2023-04-27 | Reiterato | Stifel | Buy |
| 2023-04-27 | Reiterato | TD Cowen | Market Perform |
| 2023-04-27 | Reiterato | Truist | Buy |
| 2023-04-27 | Reiterato | Wolfe Research | Outperform |
Mostra tutto
Meta Platforms Inc Borsa (META) Ultime notizie
Meta Platforms Drops 4%, Pinterest Falls 4% as Social Media Legal Risk Resurfaces - Yahoo Finance
Why Meta Platforms Stock Is Falling Today - Yahoo Finance
What's Going On With Meta Platforms Stock Monday? - Benzinga
Meta prepares to fight thousands of lawsuits against the company - The American Bazaar
Trial against Meta over alleged harm to children begins Tuesday - WRNJ Radio
Meta Platforms Inc Stock (META) Moved Down by 3.63% on Aug 17: Facts Behind the Movement - TradingKey
Meta Faces $1.4 Trillion Claim as U.S. Cash Markets Open; Company Holds $90 Billion in Reserves - TechStock²
BABA Stock Gains On Launching QwenAI Model To Challenge Meta's Lead In Open-Source AI - Yahoo Finance
Beth Israel Loses Bid to Toss Suit Over Google, Meta Disclosures - Bloomberg Law News
What's at stake as Meta faces potential landmark trial in U.S. federal court - CBC
Bill Ackman Bets Big on Magnificent 7 Stocks, But Only Loves 3 of Them - Benzinga
Four States Take Meta to Trial in California, the Latest Front in Sprawling Multidistrict Fight - Tech Policy Press
States seek $1.4 trillion -- yes, trillion -- from Meta over alleged harm to kids - ktvu.com
Meta faces major social media addiction trial this week: What to watch - Yahoo Finance
Meta Uses AI Detection To Remove More Teen Accounts In Australia 08/17/2026 - MediaPost
Meta’s Lawyers Say A Loss Could Cost $1.4 Trillion. Trial That Could Determine The Future Of Zuckerberg’s AI Ambitions Is Underway. - Yahoo Finance
Meta Faces A $1.4 Trillion Reckoning In Latest Trial Over Social Media Addiction - Engadget
States Take Meta to Trial in California in The Biggest Fight Yet Over Social Media Harms to Children - Broadband Breakfast
Alphabet, Meta, and Microsoft Are Hiding $3 Trillion in Debt On the AI Boom’s Hidden Ledger - Yahoo Finance
Meta continues legal fight following loss in New Mexico - KFOX
Tech stocks today: Anthropic's huge haul, Meta trial to kick off - Yahoo Finance
Meta, BlackRock's $14B Texas data center faces insurance risksFT (META:NASDAQ) - Seeking Alpha
History Says a $10,000 Investment in the QQQ Will Be Worth $66,000 in 10 Years - The Motley Fool
Meta heads to child safety trial facing financial damages as large as $1.4 trillion - Fortune
What Could Meta Platforms (META) Off Balance Sheet AI Financing Mean For Investors? - Yahoo Finance
Meta trial: States allege Facebook, Instagram addicted kids - Yahoo Finance
Meta faces ‘astronomical’ consequences as legal fight reaches critical moment in California - CNBC
The Meta jurors who won't decide Meta's fate - Reuters
Meta Adds More Incentives for Paying Users - ALM Corp
AI data center debt is getting more expensive, and Meta's $12.5 billion El Paso deal proves it - MarketScale
New Mexico’s attorney general pushes new social media safety laws after $900m court victory over Meta - The Guardian
Google, Amazon, and Meta All Just Raised Capex Guidance Again. This Boring Industrial Wins No Matter Whose AI Infrastructure Is Best. - The Globe and Mail
Meta faces landmark US trial over alleged harm to children from Instagram, Facebook - Anadolu Ajansı
Meta Platforms, Inc. $META Shares Sold by Spire Wealth Management - marketbeat.com
Secure Asset Management LLC Acquires 2,849 Shares of Meta Platforms, Inc. $META - marketbeat.com
Salem Investment Counselors Inc. Increases Position in Meta Platforms, Inc. $META - marketbeat.com
AI Giants Will Earn $1 Trillion This Year. It May Not Be Enough - Bloomberg.com
Meta heads to court in a landmark trial about kids and social media addiction - NPR
Brookstone Capital Management Increases Position in Meta Platforms, Inc. $META - marketbeat.com
BDFS Capital LLC Increases Stock Position in Meta Platforms, Inc. $META - marketbeat.com
Altrafin AG Decreases Stake in Meta Platforms, Inc. $META - marketbeat.com
Meta appeals EU interim antitrust order targeting WhatsApp - MLex
Meta to face massive social media addiction trial Tuesday - Yahoo Finance
Meta is in the dock again – but this is the big one - The Observer
States take Meta to trial in California in the biggest fight yet over social media harms to children - The Seattle Times
If Meta loses this trial, Instagram and Facebook could change forever - BBC
Meta may be forced to permanently change Instagram and Facebook due to a U.S. court case - Українські Національні Новини (УНН)
Alibaba’s AI models reach 3 billion downloads, outpacing Meta and Google - straitstimes.com
$Meta Platforms (META.US)$ - Moomoo
Damages Could Reach $1.4 Trillion in Landmark Meta Social Media Addiction Trial - Benzinga
Should You Buy Meta Platforms Stock Below $600 Before Mark Zuckerberg Unveils Its AI Cloud Business? Here's My Honest Take - The Motley Fool
Meta Platforms Inc Azioni (META) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Meta Platforms Inc Azioni (META) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Olivan Javier | Chief Operating Officer |
Aug 10 '26 |
Sale |
602.70 |
434 |
261,573 |
5,856 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):